News & Media

October 31, 2012

CIRM Scholar Nareg Djabrayan, working with MCDB Professor Joel Rothman, found that the well known Notch signaling pathway causes C. elegans cells to commit to a particular identity, such as a skin or brain cell. When the Notch pathway was blocked by genetic manipulation, the researchers discovered that they could force cells to change their destiny, such that they instead became cells of the intestine. Reprogramming of one somatic cell type to another might be useful in strategies for regeneration of tissue damaged by injury or disease. Results were reported in the November 1 issue of Genes and Development. Nate Dudley and Erica Sommermann were also authors on the study.

October 29, 2012

Biomedical research at UC Santa Barbara has catapulted to a position of leadership in the arena of stem cell biology, offering progress toward cures for vision diseases such as macular degeneration. Stem cell research has the potential to transform the practice of medicine, by replacing diseased tissue with healthy new cells. Interdisciplinary teams of UCSB researchers –– including world-renowned faculty members recruited from the U.S. and Britain –– are leading the charge. The university’s newly renovated lab space is critical to the mission.

October 16, 2012

Amgen founder Bill Bowes gives $5 million to develop stem cell therapy for ocular disease; donation launches EMBODI, new biomedical initiative

By growing new retinal cells to replace those that have malfunctioned, scientists hope to one day create and fuse entire layers of fresh cells –– a synthetic patch akin to a contact lens –– as a treatment for age-related macular degeneration, the top cause of visual impairment among people over 60.

September 26, 2012

Congratulations to the new crop of 7 CIRM Scholars at UC Santa Barbara! After rigorous review, the Steering Committee awarded 3 Postdoctoral Scholarships and 4 Predoctoral Scholarships to support a portfolio of projects that includes investigation of stem cells in model organisms, human pluripotent stem cells, human adult stem cells, cancer stem cells, and bioengineering approaches to stem cell research.

September 12, 2012

U.S. News & World Report has ranked UC Santa Barbara number 10 in its annual listing of the “Top 30 Public National Universities” in the country, and number 41 on its list of the “Best National Universities.”

Pages